Akebia Therapeutics Inc
SWB:AX9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Akebia Therapeutics Inc
SWB:AX9
|
US |
|
A
|
AxoGen Inc
XBER:LT3
|
US |
|
C
|
Crown Castle International Corp
LSE:0I4W
|
US |
Shareholder Yield
Current shareholder yield for
AX9 is
.
Peers Comparison
Shareholder Yield
Price Appreciation
AX9 Price
Akebia Therapeutics Inc
| Average Annual Return | 16.12% |
| Standard Deviation of Annual Returns | 87.45% |
| Max Drawdown | -93% |
| Market Capitalization | 305.4m EUR |
| Shares Outstanding | 333 020 897 |
| Percentage of Shares Shorted |
N/A
|